Veterinary Pharmaceutical Product Manufacturing

Nationally yes — but NOT in Bali. KBLI 21013 (Industri Produk Farmasi untuk Hewan) is TERBUKA (100% foreign ownership) at the national level, but a PT PMA currently cannot register it in Bali (reserved for UMKM / 2026 moratorium). OSS risk at scale Besar is Rendah/Menengah-Rendah on every scope → blocked by Bali moratorium 13 May 2026 Outside Bali it is open to a PT PMA with no local partner required.

KBLI 21013 has a Menengah Rendah risk classification. Required license: NIB + Sertifikat Standar. Processing time: Otomatis.

KBLI 21013 is the Indonesian business classification code for "Industri Produk Farmasi untuk Hewan" (Veterinary Pharmaceutical Product Manufacturing). It falls under Section C of KBLI 2025, the Indonesian Standard Industrial Classification updated by BPS (Regulation 7/2025). The June 2026 KBLI 2025 transition window has closed; operators should verify the code's current OSS/NIB treatment before relying on it for licensing, reporting, or amendments.

KBLI 21013 was mapped from previous code 21013 (KBLI 2020). This is a direct match — the code number and scope remained the same. The June 2026 KBLI 2025 transition window has closed. If an NIB still relies on legacy KBLI 2020 mappings, treat the migration as overdue and verify/remediate the OSS record before new license applications, amendments, LKPM, import approvals, or investor/worker sponsorship.